Pfizer named Dr Chris Boshoff as CSO and president of R&D, effective 1st January 2025. Boshoff, previously Pfizer’s chief ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

Needham analyst Ryan MacDonald maintained a Buy rating on Veeva Systems (VEEV – Research Report) today and set a price target of $270.00.Stay ...

In the most recent trading session, Veeva Systems (VEEV) closed at $214.75, indicating a +1.43% shift from the previous trading day.

According to Benzinga Pro, Veeva Systems's peer group average for short interest as a percentage of float is 5.98%, which ...

Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Veeva Systems (NYSE:VEEV – Get Free Report) had its price objective decreased by equities research analysts at Truist ...

Highlights,Veeva Systems’ stock price decreased by 2.2% recently.,The company provides cloud-based software solutions for the life sciences sector.,Truist Financial lowered Veeva's price target to ...

Wells Fargo analyst Stan Berenshteyn believes Veeva (VEEV) appears poised to outperform the market with an attractive risk/reward setup.

Veeva Systems (NYSE:VEEV – Free Report) had its price target cut by KeyCorp from $285.00 to $255.00 in a research note issued ...

In the latest market close, Veeva Systems (VEEV) reached $217.75, with a +0.21% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 1.54%. On ...